On Tuesday, Skye Bioscience Inc (NASDAQ: SKYE) opened lower -10.53% from the last session, before settling in for the closing price of $4.18. Price fluctuations for SKYE have ranged from $1.14 to $8.26 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 42.99% over the last five years. Company’s average yearly earnings per share was noted -66.59% at the time writing. With a float of $17.86 million, this company’s outstanding shares have now reached $30.97 million.
The firm has a total of 16 workers. Let’s measure their productivity. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Skye Bioscience Inc (SKYE) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Skye Bioscience Inc is 42.35%, while institutional ownership is 41.37%. The most recent insider transaction that took place on Nov 18 ’24, was worth 97,250. In this transaction Chief Development Officer of this company sold 19,489 shares at a rate of $4.99, taking the stock ownership to the 82,259 shares. Before that another transaction happened on Nov 15 ’24, when Company’s Chief Development Officer sold 85 for $5.55, making the entire transaction worth $472. This insider now owns 101,748 shares in total.
Skye Bioscience Inc (SKYE) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.31 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -66.59% per share during the next fiscal year.
Skye Bioscience Inc (NASDAQ: SKYE) Trading Performance Indicators
Check out the current performance indicators for Skye Bioscience Inc (SKYE). In the past quarter, the stock posted a quick ratio of 11.85.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.83, a number that is poised to hit -0.31 in the next quarter and is forecasted to reach -1.40 in one year’s time.
Technical Analysis of Skye Bioscience Inc (SKYE)
Analysing the last 5-days average volume posted by the [Skye Bioscience Inc, SKYE], we can find that recorded value of 3.13 million was better than the volume posted last year of 0.73 million. As of the previous 9 days, the stock’s Stochastic %D was 52.96%.
During the past 100 days, Skye Bioscience Inc’s (SKYE) raw stochastic average was set at 56.40%, which indicates a significant increase from 45.82% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 172.57% in the past 14 days, which was higher than the 140.50% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.28, while its 200-day Moving Average is $3.12. Now, the first resistance to watch is $4.16. This is followed by the second major resistance level at $4.58. The third major resistance level sits at $4.96. If the price goes on to break the first support level at $3.36, it is likely to go to the next support level at $2.99. Should the price break the second support level, the third support level stands at $2.57.
Skye Bioscience Inc (NASDAQ: SKYE) Key Stats
There are currently 30,975K shares outstanding in the company with a market cap of 115.88 million. Presently, the company’s annual sales total 0 K according to its annual income of -26,570 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -11,100 K.
